Extending the gains in the previous six sessions, the Japanese market is significantly higher on Friday, following the broadly ...

Study data reveal how a specific sequence of cancer therapies can improve outcomes for patients with hard-to-treat lymphomasRelapsed/refractory (R/R ...

The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis and digital pathology ...

Neoadjuvant immunotherapy alone resulted in significant treatment response among most patients with mismatch-repair-deficient ...